These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22419147)

  • 61. Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(6):441-6. PubMed ID: 22859904
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
    Suh JW; Koo BK; Zhang SY; Park KW; Cho JY; Jang IJ; Lee DS; Sohn DW; Lee MM; Kim HS
    CMAJ; 2006 Jun; 174(12):1715-22. PubMed ID: 16754899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cerivastatin-induced rhabdomyolysis.
    Rodríguez ML; Mora C; Navarro JF
    Ann Intern Med; 2000 Apr; 132(7):598. PubMed ID: 10744612
    [No Abstract]   [Full Text] [Related]  

  • 65. Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.
    Jeong YH; Kim IS; Park Y; Kang MK; Koh JS; Hwang SJ; Kwak CH; Hwang JY
    JACC Cardiovasc Interv; 2010 Jul; 3(7):731-41. PubMed ID: 20650435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin.
    Mantel-Teeuwisse AK; Klungel OH; Egberts TC; Verschuren WM; Porsius AJ; de Boer A
    Drug Saf; 2004; 27(1):63-70. PubMed ID: 14720086
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
    Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
    Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Rhabdomyolysis associated with combined treatment of cerivastatin and gemfibrozil].
    Bosch Rovira T; Llompart Pou JA; Forteza-Rey J
    Rev Clin Esp; 2001 Dec; 201(12):731-2. PubMed ID: 11835892
    [No Abstract]   [Full Text] [Related]  

  • 70. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
    Sparing R; Sellhaus B; Noth J; Block F
    Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention.
    Brophy JM; Babapulle MN; Costa V; Rinfret S
    Am Heart J; 2006 Aug; 152(2):263-9. PubMed ID: 16875906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
    Turpeinen M; Tolonen A; Uusitalo J; Jalonen J; Pelkonen O; Laine K
    Clin Pharmacol Ther; 2005 Jun; 77(6):553-9. PubMed ID: 15961986
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concurrent use of clopidogrel (Plavix) and atorvastatin (Lipitor) is contraindicated.
    Masunyane L
    S Afr Med J; 2006 Jun; 96(6):474-5. PubMed ID: 16862652
    [No Abstract]   [Full Text] [Related]  

  • 74. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study.
    Neubauer H; Günesdogan B; Hanefeld C; Spiecker M; Mügge A
    Eur Heart J; 2003 Oct; 24(19):1744-9. PubMed ID: 14522569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
    Backman JT; Kyrklund C; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2002 Dec; 72(6):685-91. PubMed ID: 12496749
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin.
    Mora C; Rodríguez ML; Navarro JF
    Transplantation; 2001 Aug; 72(3):551. PubMed ID: 11502997
    [No Abstract]   [Full Text] [Related]  

  • 78. Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.
    Itkonen MK; Tornio A; Filppula AM; Neuvonen M; Neuvonen PJ; Niemi M; Backman JT
    Clin Pharmacol Ther; 2018 Sep; 104(3):495-504. PubMed ID: 29171020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
    Yasu T; Ikee R; Miyasaka Y; Chubachi H; Saito S
    Yakugaku Zasshi; 2010 Dec; 130(12):1743-50. PubMed ID: 21139402
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study.
    Blagojevic A; Delaney JA; Lévesque LE; Dendukuri N; Boivin JF; Brophy JM
    Pharmacoepidemiol Drug Saf; 2009 May; 18(5):362-9. PubMed ID: 19253920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.